Skip to main content

Nonprofit · EIN 47-3154419

CURE GM1 INCORPORATED

Also known as CURE GM1 FOUNDATION

Tax-exempt · ALBANY, CA 94706

Financials

$534K$689K2023$341K$85K2024
Revenue Expenses · by fiscal year end
Financials of CURE GM1 INCORPORATED by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$341,216$84,682$256,534$3,572,216$296$3,571,920
December 31, 2023990$533,720$689,298-$155,578$3,216,016$4,665$3,211,351
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$254,429
Program service revenue
$0
Investment income
$86,787
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$896
Other salaries and wages
$30,221
Salaries, compensation and benefits (total)
$34,325
Professional fundraising fees
$0
Legal fees
$1,838
Accounting fees
$6,145
Travel
$1,085
Program services (functional)
$63,588
Management and general (functional)
$19,494
Fundraising (functional)
$1,600

Balance sheet and other

Total assets, start of year
$3,216,016
Total assets, end of year
$3,572,216
Total liabilities, end of year
$296
Net assets, end of year
$3,571,920
Publicly traded securities
$2,732,079
Net assets without donor restrictions
$3,571,920
Gross receipts
$341,216
Employees
4
Volunteers
0
Year formed
2014
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
CHRISTINE M WAGGONERCEO
Officer
15$896
VANESSA RANGEL MILLERDIRECTOR
Trustee or director
5$0
KYLIE HARRISONSECRETARY
Trustee or director, Officer
1$0
DAVID LAWDIRECTOR
Trustee or director
0$0
BINGYUNE CHENDIRECTOR
Trustee or director
0$0
RAFAEL ESCANDONDIRECTOR
Trustee or director
5$0
DAWN BLESSINGVICE PRESIDENT
Officer
5$0
990 for the year ended December 31, 2023: 7 people
NameTitleHours / weekCompensation
VANESSA RANGEL MILLERDIRECTOR
Trustee or director
5$0
KYLIE HARRISONSECRETARY
Trustee or director, Officer
1$0
DAVID LAWDIRECTOR
Trustee or director
0$0
BINGYUNE CHENDIRECTOR
Trustee or director
0$0
RAFAEL ESCANDONDIRECTOR
Trustee or director
5$0
CHRISTINE M WAGGONERCEO
Officer
15$0
DAWN BLESSINGVICE PRESIDENT
Officer
5$0

Address and contacts

Address (IRS master file)
1492 POSEN AVE, ALBANY, CA 94706-2438
In care of
% CHRISTINE WAGGONER
Mailing address (990-N for 2014)
PO Box 6890, Albany CA 94706
Principal officer (990 for 2024)
CHRISTINE M WAGGONER, 1492 POSEN AVE, ALBANY, CA 94706
Principal officer (990-N for 2014)
Christine Waggoner, PO Box 6890, PO Box CA 94706
Signed the 990
CHRISTINE M WAGGONER, CEO
Phone
(510) 922-3311
Return prepared by
SCRUBBEDNET LLC

California records

California keeps its own records of charities and corporations. Search them by EIN 47-3154419 or by the name CURE GM1 INCORPORATED.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

SEE SCHEDULE O.THE PURPOSE OF THE ORGANIZATION IS TO RAISE FUNDS FOR MEDICAL RESEARCH FOR A RARE DISEASE CALLED GM1 GANGLIOSIDOSIS THAT HAS NO CURE OR TREATMENT OTHER THAN COMFORT MEASURES AND SYMPTOM MANAGEMENT. PROMISING RESEARCH EXISTS, BUT LACKS FUNDING. THE ORGANIZATION HOPES TO UNIT FAMILIES OF THOSE WHO SUFFER FROM THIS DISEASE AND THEIR SUPPORTERS BY FUNDRAISING FOR A CURE.

990 for the year ended December 31, 2024

Program accomplishments

  • CURE GM1 IS INVESTIGATING THE DEVELOPMENT OF NEW RESEARCH PROGRAMS. OUR CURRENT FOCUS IS THE INVESTIGATION OF AN ENZYME REPLACEMENT THERAPY (ERT). WHILE THERE HAVE BEEN GENE THERAPY AND SMALL MOLECULES TRIALS, THERE HAVE BEEN NO TRIALS FOR ERT.
    Expenses $21,196
  • CURE GM1 HAS BEEN HARD AT WORK APPLYING FOR GRANTS TO WORK TOWARDS DIVERSIFYING OUR SOURCES OF FUNDING
    Expenses $21,196
  • CURE GM1 WILL PRESENT TWO POSTERS AND ABSTRACT AT THE WORL SYMPOSIUM IN 2025. THE SUBJECTS OF THE POSTER ARE REAL-WORLD DATA ON GM1 AND DATA SHARING TO SUPPORT NATURAL HISTORY AND TO DEEPEN THE UNDERSTANDING OF GM1.
    Expenses $21,196

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
47-3154419
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2015
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H12)
Assets (IRS master file)
$3,572,216
Income (IRS master file)
$341,216

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$341,216$84,682$3,572,216IRS
990December 2023$533,720$689,298$3,216,016XML
990December 2022$521,967$219,320$3,215,700IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990-N for 2014
Officer: Christine Waggoner
December 31, 2014≤ $50,000 receipts––e-Postcard

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 47-3154419).

Questions about CURE GM1 INCORPORATED

What is the EIN of CURE GM1 INCORPORATED?
The employer identification number (EIN) of CURE GM1 INCORPORATED is 47-3154419.
Is CURE GM1 INCORPORATED tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2015.
Are donations to CURE GM1 INCORPORATED tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CURE GM1 INCORPORATED file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CURE GM1 INCORPORATED due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CURE GM1 INCORPORATED last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of CURE GM1 INCORPORATED?
The 990 for the year ended December 31, 2024 names CHRISTINE M WAGGONER.
Who are the officers and directors of CURE GM1 INCORPORATED?
The 990 for the year ended December 31, 2024 lists 7 people; 1 received compensation from the organization, the highest $896 (CHRISTINE M WAGGONER, CEO).
How much revenue does CURE GM1 INCORPORATED have?
On its 990 for the year ended December 31, 2024 it reported revenue of $341,216, expenses of $84,682 and total assets of $3,572,216 at year end.

Other nonprofits in ALBANY

All nonprofits in ALBANY · California · Medical research